eValuatIon of The ALl New Environment for crITicallY Ill Patients (VITALITY)
1 other identifier
observational
74
1 country
1
Brief Summary
The purpose of this prospective observational study is to investigate if mechanically ventilated patients who are treated in one of the new intensive care unit (ICU) rooms have less delirium compared to patients who are treated in the conventional rooms on the same ICU. The investigators will further evaluate the impact on sleep quality, circadian rhythm, global cognitive function and general outcome parameters. The investigators recorded light and noise conditions in the ICU rooms before start of the redesigning process (subproject light and noise in the intensive care unit (LiNo-ICU)). The investigators will compare data regarding light and noise in the ICU rooms before and after the redesigning process (non-patient related data; ethical vote amendment 08.05.2014).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 19, 2014
CompletedFirst Posted
Study publicly available on registry
May 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2019
CompletedApril 30, 2020
April 1, 2020
2.9 years
May 19, 2014
April 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of intensive care unit delirium
Delirium will be measured with the Confusion Assessment Method for the intensive care unit (CAM-ICU)
Participants will be followed up to 10 days after intensive care unit admission
Secondary Outcomes (34)
Circadian plasma melatonin level
Participants will be followed up to 10 days after intensive care unit admission
Circadian plasma cortisone level
Participants will be followed up to 10 days after intensive care unit admission
Gene expression of clock genes in blood monocytes
Participants will be followed up to 10 days after intensive care unit admission
Cholinesterase activity in blood
Participants will be followed up to 10 days after intensive care unit admission
Core body temperature
Participants will be followed up to 10 days after intensive care unit admission
- +29 more secondary outcomes
Study Arms (2)
Critically ill patients in the newly designed ICU rooms
Critically ill patients treated in one of the newly designed ICU rooms.
Critically ill patients in the conventional ICU rooms
Critically ill patients treated in one of the conventional rooms on the same ICU.
Eligibility Criteria
Critically ill patients
You may qualify if:
- Male and female patients with age ≥ 18 years
- Expected intensive Care unit stay ≥ 48 hours
- Invasive mechanical ventilation or non-invasive mechanical ventilation (with positive ventilation pressure \>6 hours/day and high flow \>30 liters) on the day of intensive care unit admission
You may not qualify if:
- Patients with psychiatric diseases
- Patients with a history of stroke and known residual cognitive deficits
- Patients with a history of cardiopulmonary arrest or pulseless electric activity with cardiopulmonary resuscitation followed by therapeutic hypothermia during entire hospital stay
- Analphabetism
- Anacusis or Hypoacusis with hearing aid device, Amaurosis
- Non-German speaking
- Allergies to any substance of the electrode fixing material
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- History of sleep disorders
- History or suspicion of hypoxic brain damage (e.g. intracranial bleeding)
- Patients with an open chest after cardiac surgery
- The informed consent of the patient or the subject's legally acceptable representative can´t be obtained in time
- Patient has a power of attorney or patient's provision, where he/she refuses participation in any clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Claudia Spieslead
Study Sites (1)
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charité- Universitätsmedizin
Berlin, 13353, Germany
Related Publications (2)
Schmidt S, Heinrich M, Wernecke KD, Spies C, Hancke L, Mueller A, Luetz A. Modification in ICU design may influence circadian serum cholinesterase activities: a proof-of-concept pilot study. Intensive Care Med Exp. 2024 Dec 23;12(1):120. doi: 10.1186/s40635-024-00709-5.
PMID: 39715945DERIVEDSpies C, Piazena H, Deja M, Wernecke KD, Willemeit T, Luetz A; ICU Design Working Group. Modification in ICU Design May Affect Delirium and Circadian Melatonin: A Proof of Concept Pilot Study. Crit Care Med. 2024 Apr 1;52(4):e182-e192. doi: 10.1097/CCM.0000000000006152. Epub 2023 Dec 19.
PMID: 38112493DERIVED
Study Officials
- STUDY DIRECTOR
Claudia Spies, MD, Prof.
Charité University, Berlin, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum
Study Record Dates
First Submitted
May 19, 2014
First Posted
May 21, 2014
Study Start
May 1, 2014
Primary Completion
April 1, 2017
Study Completion
November 11, 2019
Last Updated
April 30, 2020
Record last verified: 2020-04